Human MCP-2(CCL8) Recombinant

Catalog #

90213-A

$130 *

Size: 5 µg

Qty

Bulk/Custom

Add to Favorites

*US Pricing only. For international pricing, please contact your local distributor.

●

Purchase

●

Description

Recombinant MCP-2 is a disulfide-linked monomeric protein consisting of 77 amino acid residues and migrates as an approximately 9 kDa protein under non-reducing conditions and reducing conditions in SDS-PAGE. Optimized DNA sequence encoding human MCP-2 (CCL8) mature chain was expressed in E. coli.

●

Synonyms

MCP-2, CCL8, Chemokine (C-C Motif) Ligand 8, Monocyte Chemoattractant Protein 2, HC14, SCYA10, MCP2

Product Info

Storage and Usage

Citations

Species

Human

Host Species/Expression System

E. coli

Purity

≥98% by SDS-PAGE and HPLC

Format

lyophilized protein

Formulation

Lyophilized from a 0.2 µm filtered 20 mM Phosphate buffer, 100 mM NaCl, pH 7.5.

9 kDa

Endotoxin Level

<0.1 ng/µg (1 EU/µg), using the LAL gel clot method.

Amino Acids

29–109

Biological Activity

The ED₅₀ was determined by the dose-dependent chemo-attraction of THP1 leukemic cells and was found to be ≤ 50 ng/ml, corresponding to a specific activity of >5x 10⁴ units/mg.

Genbank #

P80075

UniProt #

P80075

Background

Monocyte chemotactic protein MCP-2 is a C-C chemokine.It shares over 60% amino acid identity with MCP-1 and MCP-3 and has about 30% identity with other C-C chemokines MIP-1alpha, RANTES, and MIP-1beta. MCP-2 is chemotactic for and activates a wide variety of inflammatory cells, and its spectrum of action on leukocytes is similar to that of MCP-3, including monocytes, T lymphocytes, NK cells, basophils, mast cells, and eosinophils, but differs from MCP-1, which is not active on eosinophils. MCP-2 has been proposed to interact with multiple C-C chemokine receptors, including those used by MCP- 1 and MCP-3. However, since leukocytes express a multiplicity of chemokine receptors with promiscuous binding and functional properties, it is difficult to identify the receptors used by a given ligand on these cells.

References

1. J. Immunol., Jan 2009, 182: 522 - 529.
2. Eur. Respir. J., Dec 2008, 32: 1607 - 1615.
3. Journal of Renin-Angiotensin-Aldosterone System, Mar 2007, 8: 45 - 50.

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Human MCP-2(CCL8) Recombinant

PRODUCTS

SERVICES

RESOURCES

COMPANY